AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10589806 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus subgingival application of metronidazole 25% dental gel (Elyzol) 5x during 10 days
Number of subjects: 30
Study 10589806 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 30
Study 8611355 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with chronic renal failure on a well‐balanced protein‐restricted diet
Number of subjects: 39
Study 8611355 — intervention group
Group type: COMPARATOR
Intervention: Children with chronic renal failure with a normal protein intake
Number of subjects: 39
Study 8611355 — intervention group
Group type: COMPARATOR
Intervention: Healthy children
Number of subjects: 39
Study 1755555 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (IN) 0.15 mg.kg‐1
Number of subjects: 29
Study 1755555 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (IM) 0.15 mg.kg‐1
Number of subjects: 29
Study 1755555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 29
Study 6136794 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-system (sodium hypochlorite)
Number of subjects: 62
Study 6136794 — intervention group
Group type: COMPARATOR
Intervention: Standard CAPD method
Number of subjects: 62
Study 31818232 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (250 mg/day)
Number of subjects: 50
Study 31818232 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mg/day)
Number of subjects: 50
Study 31839626 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental sit-to-stand (ISTS) exercise
Number of subjects: 22
Study 28560655 — intervention group
Group type: EXPERIMENTAL
Intervention: BioResponse DIM® (BR-DIM) at 150 mg twice daily
Number of subjects: 130
Study 28560655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy
Number of subjects: 103
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from symptom onset to reperfusion (OTR)
Number of subjects: 103
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from onset to CT
Number of subjects: 103
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from CT to reperfusion
Number of subjects: 103
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: OTR time in ASPECTS<8 patients
Number of subjects: 103
Study 26956258 — intervention group
Group type: EXPERIMENTAL
Intervention: OTR time in ASPECTS≥8 patients
Number of subjects: 103
Study 24370467 — intervention group
Group type: EXPERIMENTAL
Intervention: PPPM
Number of subjects: 174
Study 24370467 — intervention group
Group type: EXPERIMENTAL
Intervention: FPS‐R
Number of subjects: 174
Study 24370467 — intervention group
Group type: EXPERIMENTAL
Intervention: PPPM and FPS‐R
Number of subjects: 174
Study 22535515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative context
Number of subjects: 0
Study 22535515 — intervention group
Group type: COMPARATOR
Intervention: Competitive context
Number of subjects: 0
Study 19574776 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus vaginal irradiation (319 patients)
Number of subjects: 645
Study 19574776 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (326 patients)
Number of subjects: 645
Study 16858613 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month physical training programme (TRN)
Number of subjects: 19
Study 16858613 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 19
Study 15316515 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental control measures attempted by parents (82% of parents attempted at least one measure)
Number of subjects: 896
Study 11737019 — intervention group
Group type: EXPERIMENTAL
Intervention: Global motor rating scale measuring postural‐motor, locomotor (PML), and eye‐hand grip coordination (EHGC).
Number of subjects: 123
Study 11737019 — intervention group
Group type: EXPERIMENTAL
Intervention: Global motor rating scale.
Number of subjects: 123
Study 9679572 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 lymphadenectomy
Number of subjects: 0
Study 9679572 — intervention group
Group type: EXPERIMENTAL
Intervention: D4 lymphadenectomy
Number of subjects: 0
Study 9679572 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with oral fluorouracil
Number of subjects: 0
Study 8023998 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) infusion (plasma AVP 16-20 pg/ml)
Number of subjects: 0
Study 8023998 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 2920304 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 40 mg, three times daily
Number of subjects: 15
Study 2920304 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide 200 mg single dose, three days after propranolol discontinuation
Number of subjects: 15
Study 2920304 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propranolol and disopyramide
Number of subjects: 15
Study 1093108 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (dosage range: 0.2 to 1.9 mg/kg)
Number of subjects: 98
Study 1093108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 28791521 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer (IC) module
Number of subjects: 54
Study 28791521 — intervention group
Group type: COMPARATOR
Intervention: In-person genetic counseling (GC)
Number of subjects: 54
Study 27092929 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based (CB) low vision rehabilitation services
Number of subjects: 55
Study 27092929 — intervention group
Group type: COMPARATOR
Intervention: Home-based (HB) low vision rehabilitation services
Number of subjects: 55
Study 24119989 — intervention group
Group type: EXPERIMENTAL
Intervention: High K meal (36 mmol potassium)
Number of subjects: 32
Study 24119989 — intervention group
Group type: COMPARATOR
Intervention: Low K meal (6 mmol potassium)
Number of subjects: 32
Study 24119989 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 32
Study 24119989 — intervention group
Group type: EXPERIMENTAL
Intervention: High K meal and Low K meal
Number of subjects: 32
Study 21789646 — intervention group
Group type: EXPERIMENTAL
Intervention: Dor fundoplication
Number of subjects: 60
Study 21789646 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet fundoplication
Number of subjects: 60
Study 21789646 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Dor and Toupet)
Number of subjects: 60
Study 20555276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest interval of 60 seconds (P60)
Number of subjects: 10
Study 20555276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest interval of 90 seconds (P90)
Number of subjects: 10
Study 20555276 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest interval of 120 seconds (P120)
Number of subjects: 10
Study 20555276 — intervention group
Group type: EXPERIMENTAL
Intervention: All protocols (P60, P90, P120)
Number of subjects: 10
Study 20555276 — intervention group
Group type: EXPERIMENTAL
Intervention: P90 and P120
Number of subjects: 10
Study 18455169 — intervention group
Group type: EXPERIMENTAL
Intervention: IV semapimod
Number of subjects: 242
Study 18455169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 16339502 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) (0.625 mg/d)
Number of subjects: 8
Study 16339502 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE plus medroxyprogesterone acetate (MPA) (2.5 mg/d)
Number of subjects: 8
Study 16339502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12801217 — intervention group
Group type: EXPERIMENTAL
Intervention: Rackets with string tension differences of up to 98 N (10 kg)
Number of subjects: 41
Study 12801217 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants wearing earplugs during the test
Number of subjects: 41
Study 11040726 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia computer game for asthma self-management
Number of subjects: 0
Study 11040726 — intervention group
Group type: COMPARATOR
Intervention: Usual-care comparison
Number of subjects: 0
Study 8888298 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative motion during adaptation
Number of subjects: 0
Study 8888298 — intervention group
Group type: COMPARATOR
Intervention: Stationary surround contours in the nonadapting eye
Number of subjects: 0
Study 8888298 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of surround contours during adaptation
Number of subjects: 0
Study 8888298 — intervention group
Group type: COMPARATOR
Intervention: Presence or absence of surround contours during the test phase
Number of subjects: 0
Study 2069490 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 50 micrograms
Number of subjects: 27
Study 2069490 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 25 micrograms
Number of subjects: 27
Study 2069490 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 27
Study 6876944 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (20 mg)
Number of subjects: 10
Study 6876944 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 10
Study 6876944 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline (30 mg)
Number of subjects: 10
Study 6876944 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline (15 mg) and Propranolol (20 mg)
Number of subjects: 10
Study 6876944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30935515 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg/day dried ginger powder for 12 weeks
Number of subjects: 46
Study 30935515 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 12 weeks
Number of subjects: 46
Study 29351783 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (RCA)
Number of subjects: 25
Study 29351783 — intervention group
Group type: COMPARATOR
Intervention: Saline flushes
Number of subjects: 25
Study 27179731 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer generation permanent polymer-coated drug-eluting stents (DES)
Number of subjects: 1423
Study 25199531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine-month regimen including clofazimine and high-dose moxifloxacin (can be extended to 11 months if needed)
Number of subjects: 400
Study 25199531 — intervention group
Group type: COMPARATOR
Intervention: Control regimen as recommended by the World Health Organization (WHO) for MDR-TB
Number of subjects: 400
Study 22897540 — intervention group
Group type: EXPERIMENTAL
Intervention: Young Parenthood Program (YPP), a 10-week counseling program administered during pregnancy
Number of subjects: 105
Study 22897540 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 105
Study 21311483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantogam
Number of subjects: 0
Study 21311483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17980021 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A practices (didactic training and course materials in oral health screening, referral, counseling, and application of fluoride varnish)
Number of subjects: 121
Study 17980021 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B practices (same as Group A + weekly conference calls providing advice and support)
Number of subjects: 121
Study 17980021 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C practices (same as Group B + in‐office visits providing hands‐on advice and support)
Number of subjects: 121
Study 17980021 — intervention group
Group type: COMPARATOR
Intervention: Group A practices
Number of subjects: 121
Study 17980021 — intervention group
Group type: COMPARATOR
Intervention: Group B practices
Number of subjects: 121
Study 17980021 — intervention group
Group type: COMPARATOR
Intervention: Group C practices
Number of subjects: 121
Study 15817595 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg taken daily for 5 years
Number of subjects: 347
Study 15817595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study 12226607 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT primer and adhesive applied to a noncontaminated surface
Number of subjects: 240
Study 12226607 — intervention group
Group type: EXPERIMENTAL
Intervention: Assure primer applied after saliva contamination
Number of subjects: 240
Study 12226607 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP primer applied after saliva contamination
Number of subjects: 240
Study 12226607 — intervention group
Group type: EXPERIMENTAL
Intervention: Assure primer reapplied after saliva contamination
Number of subjects: 240
Study 12226607 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP reapplied after saliva contamination
Number of subjects: 240
Study 12226607 — intervention group
Group type: EXPERIMENTAL
Intervention: Assure adhesive applied after saliva contamination of the primer
Number of subjects: 240
Study 10374174 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 U/kg/week of recombinant GH
Number of subjects: 30
Study 10374174 — intervention group
Group type: COMPARATOR
Intervention: Control group, no treatment
Number of subjects: 30
Study 7786929 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (2-3 months, targeting 16-20 Hz beta activity and reducing 4-8 Hz theta activity)
Number of subjects: 23
Study 7786929 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 23
Study 2133014 — intervention group
Group type: COMPARATOR
Intervention: Milrinone (12.5 to 75 microns/kg, intravenously)
Number of subjects: 15
Study 2133014 — intervention group
Group type: COMPARATOR
Intervention: Milrinone (at rest)
Number of subjects: 15
Study 374692 — intervention group
Group type: EXPERIMENTAL
Intervention: Large amounts of ascorbic acid, niacinamide, calcium pantothenate, and pyridoxine added to a low carbohydrate-high protein diet
Number of subjects: 20
Study 374692 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (control)
Number of subjects: 20
Study 374692 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-administered behavior checklist (regardless of group assignment)
Number of subjects: 20
Study 374692 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary excretion of kryptopyrrole
Number of subjects: 20
Study 31808514 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on expanded TNM staging
Number of subjects: 595
Study 31808514 — intervention group
Group type: COMPARATOR
Intervention: TNM staging system
Number of subjects: 595
Study 31808514 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 595
Study 29289934 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord clamping at 60 seconds
Number of subjects: 200
Study 29289934 — intervention group
Group type: COMPARATOR
Intervention: Umbilical cord clamping at 10 seconds
Number of subjects: 200
Study 29289934 — intervention group
Group type: COMPARATOR
Intervention: Umbilical cord clamping at 180 seconds
Number of subjects: 200
Study 25761786 — intervention group
Group type: EXPERIMENTAL
Intervention: Low erosive blackcurrant drink
Number of subjects: 21
Study 25761786 — intervention group
Group type: COMPARATOR
Intervention: Commercially available conventional apple and blackcurrant fruit juice drink
Number of subjects: 21
Study 25761786 — intervention group
Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 21
Study 23132732 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized humor therapy group
Number of subjects: 99
Study 23132732 — intervention group
Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 99
Study 20676689 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable silicone gastric banding (LASGB)
Number of subjects: 100
Study 20676689 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 100
Study 19856521 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of A/Vietnam/1194/2004 given 6 months apart
Number of subjects: 48
Study 19856521 — intervention group
Group type: COMPARATOR
Intervention: Two doses of A/Vietnam/1194/2004 given 21 days apart
Number of subjects: 48
Study 19856521 — intervention group
Group type: EXPERIMENTAL
Intervention: A/Indonesia/05/2005 booster dose after one primary dose of A/Vietnam/1194/2004
Number of subjects: 48
Study 16740843 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified rice meal (approximately 15 mg of iron per day as ferric pyrophosphate)
Number of subjects: 186
Study 16740843 — intervention group
Group type: COMPARATOR
Intervention: Control meal without added iron
Number of subjects: 186
Study 15634526 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose impulsion chemotherapy (HDIC)
Number of subjects: 126
Study 15634526 — intervention group
Group type: COMPARATOR
Intervention: Low dose density chemotherapy (LDDC)
Number of subjects: 126
Study 15634526 — intervention group
Group type: COMPARATOR
Intervention: Comparison of HDIC and LDDC
Number of subjects: 126
Study 11706624 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP)
Number of subjects: 103
Study 11706624 — intervention group
Group type: COMPARATOR
Intervention: Surgery only (Control)
Number of subjects: 103
Study 11706624 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus IHCP
Number of subjects: 103
Study 8990427 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-methyl prostaglandin F2 alpha (250 micrograms, intramuscularly every 20 minutes, maximum three doses)
Number of subjects: 67
Study 8990427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline, intramuscularly every 20 minutes, maximum three doses)
Number of subjects: 67
Study 8302395 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 22
Study 8302395 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study 3525273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketoconazole (400 mg for 5 days)
Number of subjects: 42
Study 3525273 — intervention group
Group type: COMPARATOR
Intervention: Topical miconazole (1200 mg a single dose)
Number of subjects: 42
Study 30281652 — intervention group
Group type: EXPERIMENTAL
Intervention: High Activity prosthesis
Number of subjects: 22
Study 30281652 — intervention group
Group type: COMPARATOR
Intervention: Low Activity prosthesis
Number of subjects: 22
Study 27903389 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 541
Study 27903389 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 541
Study 27903389 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 541
Study 24506479 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Record (CR)
Number of subjects: 120
Study 24506479 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Display (CD)
Number of subjects: 120
Study 24506479 — intervention group
Group type: COMPARATOR
Intervention: Non-Color Record (non-CR)
Number of subjects: 120
Study 24506479 — intervention group
Group type: COMPARATOR
Intervention: Non-Color Display (non-CD)
Number of subjects: 120
Study 21558457 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 10 to 20 mg/kg/d orally
Number of subjects: 151
Study 19616987 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day istradefylline
Number of subjects: 176
Study 19616987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 18392461 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative pleural drainage for 3 hours
Number of subjects: 56
Study 18392461 — intervention group
Group type: COMPARATOR
Intervention: No postoperative pleural drainage
Number of subjects: 56
Study 15883317 — intervention group
Group type: EXPERIMENTAL
Intervention: AN1792/QS-21 (225 mug plus QS-21 50 mug)
Number of subjects: 372
Study 15883317 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 372
Study 12813116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) plus SSRIs when indicated, initiated at a median of 17 days after MI for a median of 11 sessions over 6 months.
Number of subjects: 2481
Study 12813116 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 2481
Study 12813116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) plus SSRIs when indicated
Number of subjects: 2481
Study 11069801 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 30
Study 11069801 — intervention group
Group type: COMPARATOR
Intervention: Breathing exercises with an incentive spirometer (control)
Number of subjects: 30
Study 9272925 — intervention group
Group type: EXPERIMENTAL
Intervention: NebuChamber (CFC-free MDI)
Number of subjects: 10
Study 9272925 — intervention group
Group type: COMPARATOR
Intervention: Turbuhaler (DPI)
Number of subjects: 10
Study 8497020 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery training programme (visual and kinaesthetic imagery, internal and external perspectives), 6 weeks, bi-weekly sessions of 15 min each.
Number of subjects: 44
Study 8497020 — intervention group
Group type: COMPARATOR
Intervention: Control group (competitive strategy unrelated to performance task), 6 weeks, bi-weekly sessions of 15 min each.
Number of subjects: 44
Study 3576125 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric pH monitoring with an antimony electrode
Number of subjects: 20
Study 3576125 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourly aspiration of gastric juice
Number of subjects: 20
Study 27694549 — intervention group
Group type: EXPERIMENTAL
Intervention: Socratic questioning-based sessions on ethics and moral dilemmas (experiment group 1)
Number of subjects: 103
Study 27694549 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour workshop (experiment group 2)
Number of subjects: 103
Study 27694549 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study 27244221 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human Bile Salt-Stimulated Lipase (rhBSSL)
Number of subjects: 415
Study 27244221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415